Related Experiment Video
Updated: Feb 2, 2026

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
1.3K
Obesity and thermoregulation
1Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China and Institute of Biological and Life Sciences, University of Aberdeen, Aberdeen, Scotland, United Kingdom.
Handbook of Clinical Neurology
|November 21, 2018
Summary
Subcutaneous fat acts as insulation, affecting body temperature regulation. While beneficial in cold, obesity can hinder heat loss and increase heat stress risk.
Area of Science:
- Physiology
- Thermoregulation
- Obesity Research
Background:
- Subcutaneous adipose tissue has lower thermal conductivity than lean tissue.
- In some mammals, adipose tissue forms a continuous insulating layer.
- Fat distribution varies, potentially balancing energy storage and heat loss.
Purpose of the Study:
- To investigate the role of subcutaneous fat in thermoregulation.
- To explore the relationship between obesity and heat regulation in humans and animals.
Main Methods:
- Review of existing literature on thermal conductivity of fat and lean tissue.
- Analysis of studies on human immersion in cool water.
- Examination of the relationship between obesity and ambient temperature.
Main Results:
- Obesity in humans provides insulation in cool water, reducing cooling rate and metabolic heat production.
- Obesity impedes heat loss, increasing susceptibility to heat stress.
- The link between obesity levels and ambient temperature is weak, especially when controlling for socioeconomic factors.
Conclusions:
- Obesity significantly impacts thermoregulatory physiology.
- Thermoregulatory capacity is unlikely to be a primary driver of obesity differences.
- Subcutaneous fat plays a crucial role in thermal insulation and body temperature regulation.
Related Concept Videos
Thermoregulation
2.4K
The human body has a sophisticated thermoregulation system that employs negative feedback mechanisms to maintain an optimal core temperature. When the core temperature drops, peripheral and central thermoreceptors send signals to the hypothalamus, activating the heat-promoting center. This center triggers several responses aimed at increasing the core temperature. First, vasoconstriction reduces the flow of warm blood from internal organs to the skin so that the heat is not lost from the skin,...
2.4K
Obesity
1.3K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.3K
Drug Dosing: Obese Patients
266
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
266
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
282
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
282
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
182
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
182

